Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Filings indexed 1,253 across all filing types
Latest filing 2024-01-16 Board/Management Inform…
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is used for current reports on significant events. The content specifically announces the appointment of a new director to the Board of Directors, including details about the director's background, compensation, and related agreements. This matches the description of Board/Management Information filings, which cover announcements of changes in the company's board or senior management. The document is not a full financial report, earnings release, or other report type, but rather a regulatory filing announcing a management change. Therefore, the appropriate classification is MANG (Board/Management Information). The document length and detail support a high confidence in this classification.
2024-01-16 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text includes preliminary financial results for the fourth quarter and full year ended December 30, 2023, and mentions a press release and supplemental earnings presentation as exhibits. It explicitly states that the information is preliminary and that full results will be discussed later. The document does not contain full financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). Instead, it is a current report announcing preliminary financial results and related disclosures. Therefore, the filing type corresponds to a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings like Form 8-K that do not fit other specific categories.
2024-01-10 English
FORM 4
Director's Dealing
2023-12-21 English
FORM 8-K
Legal Proceedings Report Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce unscheduled material events or corporate changes. The text specifically reports a legal event: a court decision awarding attorneys' fees related to a lawsuit involving the company and its directors. There is no financial data, earnings information, or detailed report content. The document is not an Annual Report, Earnings Release, or Management Report. It is not a proxy, voting result, or capital change announcement. The content fits best under Legal Proceedings Report (LTR) as it updates on a significant legal matter involving the company.
2023-11-22 English
10-Q
Interim / Quarterly Report Q3 2023
2023-11-08 English
FORM 3
Director's Dealing
2023-11-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.